Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300739 · ClinicalTrials.gov registry record
Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 20
- Enrollment target
NCT03300739: Completed study, sponsored by Massachusetts General Hospital.
NCT03300739 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03300739 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is an observational pilot study focused on collecting data on clinical variables that can improve the understanding of potential predictors of disease exacerbation and readmissions in COPD patients. The study aim is to understand how the variability of clinical parameters (respiratory rate, forced expiratory volume in one second, and oxygen saturation), physical activity and quality of life is associated with the risk of exacerbation in COPD patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03300739
The ClinicalTrials.gov registry entry for NCT03300739 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03300739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03300739 about?
NCT03300739 is a clinical study titled "Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients". This is an observational pilot study focused on collecting data on clinical variables that can improve the understanding of potential predictors of disease exacerbation and readmissions in COPD patients. The study aim is to understand how the variability of clinical parameters (respiratory rate, for...
What is the current status of trial NCT03300739?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-12. Estimated completion is 2019-09.
Who is sponsoring clinical trial NCT03300739?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.